Single mRNA molecules demonstrate probabilistic movement in living mammalian cells D Fusco, N Accornero, B Lavoie, SM Shenoy, JM Blanchard, RH Singer, ... Current Biology 13 (2), 161-167, 2003 | 695 | 2003 |
Dynamics of single mRNPs in nuclei of living cells Y Shav-Tal, X Darzacq, SM Shenoy, D Fusco, SM Janicki, DL Spector, ... science 304 (5678), 1797-1800, 2004 | 555 | 2004 |
Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis Z Huang, D Tian, Y Liu, Z Lin, CJ Lyon, W Lai, D Fusco, A Drouin, X Yin, ... Biosensors and Bioelectronics 164, 112316, 2020 | 317 | 2020 |
IL28B inhibits hepatitis C virus replication through the JAK–STAT pathway L Zhang, N Jilg, RX Shao, W Lin, DN Fusco, H Zhao, K Goto, LF Peng, ... Journal of hepatology 55 (2), 289-298, 2011 | 161 | 2011 |
Kinetic differences in the induction of interferon stimulated genes by interferon‐α and interleukin 28B are altered by infection with hepatitis C virus N Jilg, W Lin, J Hong, EA Schaefer, D Wolski, J Meixong, K Goto, C Brisac, ... Hepatology 59 (4), 1250-1261, 2014 | 120 | 2014 |
Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized … MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ... Jama 327 (5), 432-441, 2022 | 107 | 2022 |
Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling K Kumthip, P Chusri, N Jilg, L Zhao, DN Fusco, H Zhao, K Goto, D Cheng, ... Journal of virology 86 (16), 8581-8591, 2012 | 97 | 2012 |
Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection DS Fierer, DT Dieterich, MI Fiel, AD Branch, KM Marks, DN Fusco, R Hsu, ... Clinical infectious diseases 56 (7), 1038-1043, 2013 | 89 | 2013 |
HCV induces transforming growth factor β1 through activation of endoplasmic reticulum stress and the unfolded protein response P Chusri, K Kumthip, J Hong, C Zhu, X Duan, N Jilg, DN Fusco, C Brisac, ... Scientific reports 6 (1), 22487, 2016 | 73 | 2016 |
A functional genomic screen reveals novel host genes that mediate interferon-alpha’s effects against hepatitis C virus H Zhao, W Lin, K Kumthip, D Cheng, DN Fusco, O Hofmann, N Jilg, ... Journal of hepatology 56 (2), 326-333, 2012 | 64 | 2012 |
Echinacea purpurea aerial extract alters course of influenza infection in mice D Fusco, X Liu, C Savage, Y Taur, W Xiao, E Kennelly, J Yuan, ... Vaccine 28 (23), 3956-3962, 2010 | 59 | 2010 |
Novel therapies for hepatitis C: insights from the structure of the virus DN Fusco, RT Chung Annual review of medicine 63 (1), 373-387, 2012 | 54 | 2012 |
EFTUD2 is a novel innate immune regulator restricting hepatitis C virus infection through the RIG-I/MDA5 pathway C Zhu, F Xiao, J Hong, K Wang, X Liu, D Cai, DN Fusco, L Zhao, ... Journal of virology 89 (13), 6608-6618, 2015 | 50 | 2015 |
A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication DN Fusco, C Brisac, SP John, YW Huang, CR Chin, T Xie, H Zhao, N Jilg, ... Gastroenterology 144 (7), 1438-1449. e9, 2013 | 50 | 2013 |
Emergence of an early SARS-CoV-2 epidemic in the United States M Zeller, K Gangavarapu, C Anderson, AR Smither, JA Vanchiere, ... Cell 184 (19), 4939-4952. e15, 2021 | 47 | 2021 |
MicroRNA 130a regulates both hepatitis C virus and hepatitis B virus replication through a central metabolic pathway X Duan, S Li, JA Holmes, Z Tu, Y Li, D Cai, X Liu, W Li, C Yang, B Jiao, ... Journal of virology 92 (7), 10.1128/jvi. 02009-17, 2018 | 45 | 2018 |
Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and … S Salloum, JA Holmes, R Jindal, SS Bale, C Brisac, N Alatrakchi, ... Hepatology 64 (6), 1951-1968, 2016 | 45 | 2016 |
The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling K Goto, W Lin, L Zhang, N Jilg, RX Shao, EAK Schaefer, H Zhao, ... Journal of hepatology 59 (5), 942-948, 2013 | 41 | 2013 |
HELZ2 is an IFN effector mediating suppression of dengue virus DN Fusco, H Pratt, S Kandilas, SSY Cheon, W Lin, DA Cronkite, ... Frontiers in microbiology 8, 240, 2017 | 39 | 2017 |
SARS-CoV-2 variant vaccine boosters trial: preliminary analyses AR Branche, NG Rouphael, DJ Diemert, AR Falsey, C Losada, LR Baden, ... MedRxiv, 2022.07. 12.22277336, 2022 | 36 | 2022 |